Free Trial

SAB Biotherapeutics (SABS) SEC Filings & 10K Form

SAB Biotherapeutics logo
$3.88
+0.62 (+19.02%)
(As of 11/1/2024 ET)

Recent SAB Biotherapeutics SEC Filings

DateFilerForm TypeView
09/09/2024
7:21 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:15 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:30 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
7:00 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:30 PM
Giberson Scott (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Link David Charles (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
HAMILTON CHRISTINE E (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Lucera Erick (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SKYLER JAY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Polvino William James (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Spragens Jeffrey G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:29 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
6:30 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:00 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SKYLER JAY S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
4:15 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
8:35 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:50 PM
Bausch Christoph Lawrence (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:55 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:40 PM
Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:02 AM
RTW INVESTMENTS, LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
Form SC 13G
02/14/2024
5:28 AM
Radcliffe Capital Management, L.P. (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
Form SC 13G/A
02/02/2024
6:53 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:00 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 424B5
01/25/2024
4:00 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:21 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
8:00 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
8:34 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form DEF 14A
12/08/2023
4:26 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form PRE 14A
12/08/2023
7:00 AM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
3:33 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
Form SC 13G
11/30/2023
4:00 PM
King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
7:00 AM
Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
6:40 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
11:15 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form EFFECT
11/22/2023
3:45 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:30 PM
Ellias Helen K. (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2023
3:45 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form S-3/A
11/15/2023
8:10 PM
Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4/A
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

11/15/2023
3:30 PM
Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
Form 4/A
11/14/2023
6:00 PM
Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:50 PM
King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
4:00 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/03/2023
3:40 PM
King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SABS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners